Literature DB >> 1551056

A reversal in the long-term increase in deaths attributable to malignant melanoma.

G C Roush1, L McKay, T R Holford.   

Abstract

For a few years in the 1980s, United States mortality rates suggested a plateau in the long-term increase for malignant melanoma. However, temporary plateaus in the increase of the age-adjusted rate by year of death have occurred in previous decades, only to be followed by a continued upward increase, with a long-term rise of about 2% per year. To determine whether a cessation in the long-term increase might be in progress, death rates were analyzed by year of birth, age at death, and year of death: (1) the long-term patterns of change are best described by birth cohort rather than by time period of death, indicating that analyses by a year of birth are key to a better understanding of the long-term trends; (2) in both men and women, evidence for a change in slope begins among those born in the early 1930s; (3) the decline in the rates begins among women born since the early 1930s and among men born since the early 1950s: the slope for men is -0.2661 (95% confidence limits [CL] = -0.380 to -0.152), and, for women, the slope is -0.02354 (95% CL = -0.041 to -0.005); (4) long-term Connecticut and US mortality trends were similar in pattern and direction, and long-term Connecticut incidence rates showed a persistent increase through the 1955 to 1965 birth cohorts. These analyses suggest a persistent cessation in the long-term increase and a downward trend in death rates from this cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1551056     DOI: 10.1002/1097-0142(19920401)69:7<1714::aid-cncr2820690712>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

Authors:  G G Giles; B K Armstrong; R C Burton; M P Staples; V J Thursfield
Journal:  BMJ       Date:  1996-05-04

2.  An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.

Authors:  Nicholas R Kurtansky; Stephen W Dusza; Allan C Halpern; Rebecca I Hartman; Alan C Geller; Ashfaq A Marghoob; Veronica M Rotemberg; Michael A Marchetti
Journal:  J Invest Dermatol       Date:  2021-12-11       Impact factor: 7.590

3.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

4.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

5.  Melanoma survivorship: research opportunities.

Authors:  Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

6.  Overview of ultraviolet radiation and cancer: what is the link? How are we doing?

Authors:  M A Weinstock
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

7.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations.

Authors:  G Severi; G G Giles; C Robertson; P Boyle; P Autier
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

8.  Trends of skin cancer in the Canton of Vaud, 1976-92.

Authors:  F Levi; S Franceschi; V C Te; L Randimbison; C La Vecchia
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.